David L. Lacey - 03 Jun 2021 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role: Director
Signature: /s/ Carolyn Tang, Attorney-in-Fact
Issuer symbol: RCUS
Transactions as of: 03 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 07 Jun 2021, 16:38:10 UTC
Previous filing: 24 May 2021
Next filing: 11 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCUS	Common Stock	Award	$0	+3,000	+8.5%	$0.000000	38,352	03 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCUS	Stock Option (Right to Buy)	Award	$0	+14,100		$0.000000	14,100	03 Jun 2021	Common Stock	14,100	$24.79	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of restricted stock units that vest 100% on the earlier of June 3, 2022 or the next annual meeting of the stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
F2	The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.